www.rupeedesk.in
Stocks of major pharmaceutical companies are likely to continue their upward rally in the coming week given the lack of any negative triggers. Most stocks in the pharmaceutical sector gained on this week's trading session. Scrips of Divi's Laboratories Ltd, Biocon Ltd, Cipla Ltd and Jubilant Life Sciences Ltd closed up 3.8%, 2.1%, 1.8% and 1.6% respectively from their previous closes. The S&P BSE Healthcare Index yesterday closed at 10000.55 points crossing the 10,000 mark for the first time. Buying Cipla's stocks while maintaining a neutral stand on other major stocks such as Dr Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Ranbaxy Laboratories Ltd and Lupin Ltd.
Midcap stocks have rallied upwards and some stocks, which had not participated in the earlier rally of large-cap stocks, will continue to press. Small-cap and mid-cap stocks in pharma are having a good run and they will pursue their run. We expects the pharmaceutical sector to trade from flat to positive in the coming week. We sees the stocks of Divi's Laboratories outperforming other stocks next week, while expecting stocks of Sun Pharma to underperform as they're seen trading flat.
Stocks of major pharmaceutical companies are likely to continue their upward rally in the coming week given the lack of any negative triggers. Most stocks in the pharmaceutical sector gained on this week's trading session. Scrips of Divi's Laboratories Ltd, Biocon Ltd, Cipla Ltd and Jubilant Life Sciences Ltd closed up 3.8%, 2.1%, 1.8% and 1.6% respectively from their previous closes. The S&P BSE Healthcare Index yesterday closed at 10000.55 points crossing the 10,000 mark for the first time. Buying Cipla's stocks while maintaining a neutral stand on other major stocks such as Dr Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Ranbaxy Laboratories Ltd and Lupin Ltd.
Midcap stocks have rallied upwards and some stocks, which had not participated in the earlier rally of large-cap stocks, will continue to press. Small-cap and mid-cap stocks in pharma are having a good run and they will pursue their run. We expects the pharmaceutical sector to trade from flat to positive in the coming week. We sees the stocks of Divi's Laboratories outperforming other stocks next week, while expecting stocks of Sun Pharma to underperform as they're seen trading flat.
